Advanced searches left 3/3

Major Depressive Disorder - Crossref

Summarized by Plex Scholar
Last Updated: 21 June 2022

* If you want to update the article please login/register

The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients

Abstract Background The depressive disorder is a leading cause of disease morbidity. MDD remission rates are much higher than ADM only after combined therapy with antidepressant drugs plus psychotherapy yields a higher MDD remission rate than ADM alone. Despite widespread patient preferences for psychotherapy, 77% of U. S. MDD patients are still treated with ADM only. Methods Enrolled patients will be those who are receiving ADM-only therapy of MDD in primary care facilities across West Virginia, one of the country's poorest and most rural states. Patients and study staff at West Virginia University School of Medicine will recruit patients and then randomly assign patients to one of three treatment arms with equal allocation: ADM only, ADM + self-guided i-CBT, and ADM + guided i-CBT. The trial seeks to determine heterogeneity of treatment effects as well as aggregate comparative treatment effects across the three arms. The key result will be episode remission based on a modified version of the patient-centered Remission from Depression Questionnaire, according to the authors. In the baseline SRQ, a wide variety of self-report predictors of MDD heterogeneity of treatment effects based on previous research will be included. We also expect that adding i-CBT to ADM would be highly variable among patients. We're hoping to establish a stable individualized treatment rule that will encourage patients and treatment providers to optimize aggregate treatment outcomes by working collaboratively when ADM therapy should be enhanced with i-CBT.

Source link: https://doi.org/10.1186/s13063-022-06438-y


Effects of Histone Modification in Major Depressive Disorder

We explore five key histone modifications, histone acetylation, histone acetylation, histone phosphorylation, histone phosphorylation, histone acetylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone hydroxybutyrylation, histone methylation, histone acetylation, histone acetylation, histone acetylation, histone acetylation, histone acetylation, histone phosphorylation, histone phosphorylation, histone acetylation, histone phosphorylation, histone phosphotylation, histone phosphorylation, histone phosphorylation, histone phosphorylation, histone acetylation, histone phosphorylation, histone phosphorylation, histone phosphoryl Hetone deacetylase inhibitors' use for MDD therapy is also discussed. In addition to the fact that a large number of MDD patients in China have been treated with traditional Chineses medicine, we also discuss some TCM therapies, such as Xiaosan, and their effects on histone modification.

Source link: https://doi.org/10.2174/1570159x19666210922150043


The Effectiveness of Exercise as a Treatment of Major Depressive Disorder in Adolescents: A Systematic Literature Review of Randomised Control Trials

Aims Major depressive disorder is the most common mental disorder among adolescents. Exercise is now a more common treatment for MDD in adults. This research was designed to determine if exercise is safe at reducing MDD symptoms and severity in adolescents, as well as its first-line treatment potential. If participants'u2019 depression was related to another disorder or health condition, they were banned from trials. Depression symptom severity was the most important outcome measure, as determined by a validated depression symptom scale. Conclusions Four trials found reduced depression scores in the exercise intervention group relative to control immediately post-intervention; of the four trials that included follow-up data, all reported higher rates of remission in the exercise intervention group than in the control group, relative to the placebo group.

Source link: https://doi.org/10.1192/bjo.2022.226


Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder

Objectives: Objectives Can be used in clinical diagnosis of bipolar disorder and major depressive disorder in clinical cases. Methods The study included 2,470 hospitalized patients in Shanghai as training sets and 2,143 in Hangzhou as test sets. Resultation The majority of these biochemical indices showed significant differences between BD and MDD groups, including white blood cell in liver function, uric acid in liver function, direct bilirubin in enzymes, lactic dehydrogenase in enzymes, and fasting blood glucose and low-density lipoprotein in glucolipid metabolism; We found the area under the curve of the predictive model to distinguish between BD and MDD to be 0. 772 among men and 0. 793 among women, with the biggest AUC of 0. 848 in the luteal phase of women, with these predictors for discrimination. Female patients may have a higher likelihood of differingiability with a conventional biochemical test than male patients.

Source link: https://doi.org/10.3389/fpsyt.2022.875141


No Sex Differences in Self-Reported Childhood Maltreatment in Major Depressive and Bipolar Disorders: A Retrospective Study

Background: We investigated whether there were any gender disparities in retrospective self-reported childhood maltreatment in Italian adult patients with significant depressive disorder or bipolar disorder, for the first time. Methods: This retrospective review used the findings from electronic medical records of patients hospitalized for a 4-week psychiatric rehabilitation program. Result: Three hundred thirty-five patients with MDD and 168 with BD were included, as well as 168 with BD. Both women and men with MDD or BD had a similar and heavy CM burden.

Source link: https://doi.org/10.3390/brainsci12060804


Prevalence and Incidence of Major Depressive Disorder in Alzheimer’s Disease: Findings from Two Databases

Background: Reports on the frequency of major depression in Alzheimer's disease are conflicting, with some indicating that it is common while others suggesting that it is unusual. Methods: We investigated the prevalence and incidence of symptom clusters meeting the NINCDS/ADRDA criteria for significant depressive disorder in two large series of patients diagnosed prospectively as probable or potential Alzheimer's disease. Both sites requested that the presence of depressed mood on direct patient examination at the time of initial review in order to meet MDD requirements. Conclusions: We found that DSM-III-R MDD is not common in AD patients.

Source link: https://doi.org/10.1159/000048627


Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder

Background: Given the increasing acceptability and legalization of cannabis in certain nations, doctors must continue to increase their knowledge of the effects of cannabis use on mood disorders. Objective This task force's report aims to investigate the relationship between cannabis use and prevalence, occurrence, diagnosis, and treatment of bipolar disorder and major depressive disorder, as well as the treatment of comorbid cannabis use disorder. The development of the Canadian Network for Mood and Anxiety Treatments recommendations was based on the Grading of Recommendations, Assessment, Development, and Evaluations approach, which was used to measure evidence and clinical conditions. 5,761 had bipolar disorder and 5,044 had major depressive disorder among those using cannabis use, and 5,044 had major depressive disorder. According to bipolar disorder and major depressive disorder, the lifetime use of cannabis use was 52%u201371% and 6%u201350%, respectively. Increased prevalence of depressive, manic, and psychotic symptoms in major depressive disorders and depressive symptoms was correlated with worsening course and symptoms of both mood and mood disorders, with more consistent links in bipolar disorder and major depressive disorder: more frequent use of cannabis in bipolar disorder and depressive disorders. In both bipolar disorder and major depressive disorder, cannabis use was associated with increased suicidality and reduced functioning. There were no results in the treatment of comorbid cannabis use disorder and major depressive disorder. Conclusions The results show that cannabis use is linked to the increase of course and functioning of bipolar disorder and major depressive disorder.

Source link: https://doi.org/10.1177/07067437221099769


Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson’s Disease

Having a temporal correlation with Parkinson's disease-causing neuroinflammatory pathways, greater depressive disorders influence more than cognition, according to a temporal correlation. Cell activation in MDD can be triggered by peripheral inflammatory agents that cross the blood-brain barrier and/or neuron c-Fos signaling. Because the brain cannot properly clear the protein aggregates, research indicating that MDD causes astrocytic damage or structural atrophy reveals the likelihood that accumulated u03b1-synuclein in the brain is aided. This review examines research into MDD and PD's interconnected pathophysiology, with a particular emphasis on glial cells and neuroinflammation.

Source link: https://doi.org/10.1159/000512657


Repetitive Transcranial Magnetic Stimulation Combined with Antidepressants for the First Episode of Major Depressive Disorder

In the treatment of the first major depressive disorder episode, the aim of this research was tosystematically investigate the safety, acceptability, and tolerability of repetitive transcranial magnetic stimulation treated with antidepressants. Methods and Methods: The primary clinical success of the Hamilton Depression Rating Scale was the pooled mean-endpoint scores. In this research, 108 random patients from two randomized controlled trials were included. In one, two, and four weeks, the hamd's mean-endpoint scores were higher than that of sham plus the antidepressants. Conclusion: According to a piece of limited evidence, repetitive transcranial magnetic stimulation may be able to raise the antidepressant effect of SSRIs in young patients with a first-episode major depressive disorder. However, HF-rTMS' acceptance and tolerability in the care of such patients are no better than an antidepressant alone.

Source link: https://doi.org/10.2174/1570159x18666200221113134


Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder

Background: Major Depressive Episodes can be used to characterize several psychiatric disorders. In a one-year naturalistic setting, the aim was to compare the effects of vortioxetine to those of other antidepressants. Methods: We examined 126 adult patients with an MDE, bipolar, or schizophrenia spectrum disorders with or without substance use disorder, the Hamilton Anxiety Rating Scale, a Visual Analogue Scale for craving, and the WHOQOL-BREF. Men got their depression with time that was quicker than women, and women got better at it. Patients with BD or SSOPDs on vortioxetine responded better than those on OADs. No. 1859 Clinical Trial Registration No.

Source link: https://doi.org/10.2174/1570159x19666210113150123

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions